Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
- Guntram Schernthaner
- , Naim Shehadeh
- , Alexander S. Ametov
- , Anna V. Bazarova
- , Fahim Ebrahimi
- , Peter Fasching
- , Andrej Janež
- , Péter Kempler
- , Ilze Konrāde
- , Nebojša M. Lalić
- , Boris Mankovsky
- , Emil Martinka
- , Dario Rahelić
- , Cristian Serafinceanu
- , Jan Škrha
- , Tsvetalina Tankova
- , Žydrūnė Visockienė
- Medical University of Vienna
- Technion-Israel Institute of Technology
- Russian Ministry of Health
- Astana Medical University
- University of Basel
- St. Claraspital AG
- Klinik Ottakring
- University Medical Center Ljubljana
- Semmelweis University
- Riga Stradins University
- Riga East Clinical Hospital
- University of Belgrade
- Shupyk National Healthcare University of Ukraine
- National Institute of Endocrinology and Diabetology
- Clinical Hospital Merkur
- University of Zagreb
- Josip Juraj Strossmayer University of Osijek
- Carol Davila University of Medicine and Pharmacy
- Nutrition and Metabolic Diseases
- Charles University
- Medical University Sofia
- Vilnius University
Research output: Contribution to journal › Article › peer-review
130
Scopus
citations